Searched for
AFFORDABLE CANCER TREATMENT
Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possibleAn expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduc...- Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullishHospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...
- Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...
- Wall Street’s $10 billion India hospital bet sparks a fight over billsWall Street has poured about $10 billion into Indian hospital chains over the past five years, with investors including Blackstone, KKR, TP...
- Karnataka flags 52x mark-up on cancer drugs, seeks Centre's interventionKarnataka conducted inspections revealing significant price disparities between hospital procurement and patient billing for cancer drugs a...
- Kerala HC says exorbitant drug prices can trigger government intervention in patented medicinesThe Kerala High Court ruled that government intervention is permissible for prohibitively priced patented medicines. The court directed the...
- Mehli Mistry steps down as trustee of Tata Medical Centre Trust, declines re-electionMehli K Mistry has decided not to seek re-election as a trustee of the Tata Medical Centre Trust. His current term is set to end on Septemb...
- India needs five-year policy to make precision cancer care afforable, says expertIndia needs a five-year roadmap to expand access to genomic testing and targeted cancer therapies for lower-income patients, oncologist Dr ...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- Before Ayushman Bharat, families sold their homes to afford treatment: J P NaddaUnion Health Minister J P Nadda said on Friday that the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana has transformed India's healthcare...
- Bharat Biotech is 'back in action' after Covid reset: Krishna Ella on TB vaccine, Nipah-Ebola shots, gene therapy, IPO plans & what’s nextBharat Biotech is “back in action” after a two-year post-Covid reset, founder Krishna Ella says, with the company expanding beyond vaccines...
- Karnataka medical institute opened by PM plans free cancer immunotherapy for patientsThe Sri Madhusudan Sai Institute plans to offer free immunotherapy for cancer patients. A new 600-bed hospital will soon launch on campus, ...
- Dr. Reddy's launches nivolumab biosimilar in IndiaDr Reddy's Laboratories has taken a significant step in cancer care with the introduction of NIVORZ, a biosimilar of nivolumab. Designed to...
- Employer-funded life insurance: How group term cover, riders and keyman insurance can strengthen your protectionThe base GTL is where most organisations start. Voluntary enhancement provides affordable cover without underwriting hurdles. Riders extend...
- Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in BrazilBiocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis re...
- Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilarCipla said its US unit has entered an exclusive partnership with China’s Qilu Pharmaceutical to license QL2107, a biosimilar of Merck’s can...
- The Rudan Brothers surprise Canadian couple with free roof repair, then transform entire home after learning wife is battling two forms of cancerThe Rudan Brothers set out to repair a Canadian couple’s damaged roof for free but decided to transform their entire home after learning th...
- Is ₹5-10 lakh health insurance cover enough? Check these 3 factors to know how much you needHealthcare costs in India are soaring due to escalating medical inflation. Experts warn that securing adequate health insurance is no longe...
- Long-term investing: One reason is good enough, and a must, to own a business. 8 stocks with an upside potential of up to 36%In today’s world, investors cannot assume that correlations that worked in the past will work in exactly the same manner now. We are in a p...
- Lord's Mark Industries outlines strategic expansion across global healthcare, advanced diagnostics & oncology; targets ₹1,550 Crore revenue in FY2027In a strategic shift, Lord's Mark Industries is set to launch an extensive healthcare expansion alongside a business demerger. This initiat...
Load More
